Alps Group Inc (ALPS)
NASDAQ: ALPS · Real-Time Price · USD
0.4150
+0.0125 (3.11%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Alps Group Market Cap
Alps Group has a market cap or net worth of $69.06 million as of August 7, 2026. Its market cap has increased by 57.88% in one year.
Market Cap
69.06M
Enterprise Value
69.19M
1-Year Change
57.88%
Ranking
Category
Stock Price
$0.42
ChartMarket Cap Chart
Since December 23, 2021, Alps Group's market cap has decreased from $143.00M to $69.06M, a decrease of -51.71%. That is a compound annual growth rate of -14.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 69.06M | -52.27% |
| Dec 31, 2025 | 144.67M | 230.19% |
| Dec 30, 2024 | 43.81M | -50.64% |
| Dec 29, 2023 | 88.76M | -41.77% |
| Dec 30, 2022 | 152.44M | 6.93% |
| Dec 30, 2021 | 142.56M | -0.30% |
| Dec 23, 2021 | 143.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OS Therapies | 71.26M |
| Acrivon Therapeutics | 70.19M |
| iBio, Inc. | 69.55M |
| XBiotech | 68.90M |
| Cingulate | 66.54M |
| MediciNova | 65.46M |
| Cardiff Oncology | 65.29M |
| Pliant Therapeutics | 65.02M |